Central Nervous System Pharmacology Practice Questions

Q: What are the CNS affections of a local anesthetic agent?

All of the above. **Explanation:** Local Anesthetic (LA) systemic toxicity (LAST) primarily affects the Central Nervous System (CNS) and the Cardiovascular system. CNS symptoms typically precede cardiovascular collapse because the brain is highly sensitive to sodium channel blockade. The progression of CNS toxicity follows a predictable pattern based on increasing plasma concentrations: 1. **Initial/Early Signs (Option B):** At low toxic levels, patients experience sensory changes such as **perioral numbness**, tingling of the tongue, a metallic taste, and tinnitus. This occurs due to the high vascularity of these areas and the sensitivity of cranial nerves. 2. **Excitatory Phase (Option A):** As levels rise, LAs selectively inhibit cortical inhibitory pathways (GABAergic neurons) while leaving excitatory pathways unopposed. This leads to agitation, muscle twitching, and eventually **grand mal convulsions**. 3. **Depressive Phase (Option C):** At very high concentrations, both inhibitory and excitatory pathways are inhibited, leading to generalized **CNS depression**. This manifests as unconsciousness, respiratory depression, and eventually coma. Since all three options represent different stages of the clinical spectrum of CNS toxicity, **Option D (All of the above)** is the correct answer. **High-Yield NEET-PG Pearls:** * **Potency vs. Toxicity:** Bupivacaine is more cardiotoxic than Lidocaine. The "CC/CNS ratio" (dose required for cardiovascular collapse vs. dose for convulsions) is lower for Bupivacaine, making it more dangerous. * **First Sign:** Perioral numbness/metallic taste is often the earliest warning sign of accidental intravascular injection. * **Management:** The specific antidote for LAST is **20% Intralipid (Lipid Emulsion Therapy)**. * **Hypercapnia/Acidosis:** Increases the risk of CNS toxicity by increasing cerebral blood flow (delivering more drug to the brain) and decreasing the seizure threshold.

Q: Which of the following is true about benzodiazepines?

GABA facilitator. **Explanation:** **1. Why "GABA Facilitator" is correct:** Benzodiazepines (BZDs) act as **positive allosteric modulators** of the GABA-A receptor. They bind to a specific site (the BZD site) located between the $\alpha$ and $\gamma$ subunits. Unlike barbiturates, BZDs do not activate the receptor directly; instead, they increase the **frequency** of chloride channel opening in the presence of GABA. This enhances the inhibitory effect of endogenous GABA, making them "GABA facilitators." **2. Why other options are incorrect:** * **A. GABA mimetic:** This term refers to drugs that can directly open chloride channels even in the absence of GABA (e.g., high-dose Barbiturates). BZDs lack this intrinsic activity, which is why they have a "ceiling effect" on CNS depression. * **C. Not a safe drug:** BZDs are considered relatively safe because of their high therapeutic index. Since they require endogenous GABA to work, they rarely cause fatal respiratory depression when taken alone (unlike barbiturates). * **D. High abuse potential:** While BZDs can lead to dependence, their abuse potential is categorized as **low to moderate** (Schedule IV) compared to opioids or barbiturates. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism Shortcut:** **B**enzodiazepines increase **F**requency (**B-F**); **B**arbiturates increase **D**uration (**B-D**) of channel opening. * **Antidote:** **Flumazenil** is a competitive BZD receptor antagonist used for overdose. * **Liver Metabolism:** For elderly patients or those with liver failure, use **LOT** drugs (**L**orazepam, **O**xazepam, **T**emazepam) as they undergo direct conjugation and do not form active metabolites. * **Drug of Choice:** BZDs are the DOC for **Status Epilepticus** (Lorazepam/Diazepam) and **Alcohol Withdrawal** (Chlordiazepoxide).

Q: Muscular rigidity caused by opioids is due to agonistic effect on which receptor?

Mu. **Explanation:** **1. Why Mu (μ) is Correct:** Opioid-induced muscle rigidity (often referred to as "Chest Wall Rigidity" or "Wooden Chest Syndrome") is primarily mediated by the **Mu (μ) opioid receptors**. This phenomenon occurs most frequently with rapid intravenous administration of potent lipophilic Mu-agonists like **Fentanyl, Sufentanil, and Remifentanil**. The underlying mechanism involves the activation of Mu receptors in the **striatum and substantia nigra** (basal ganglia), which modulates GABAergic and dopaminergic pathways, leading to increased motor neuron output and skeletal muscle contraction. **2. Why Other Options are Incorrect:** * **Kappa (κ):** These receptors are primarily associated with spinal analgesia, sedation, and miosis. Agonism here often leads to **dysphoria** and psychotomimetic effects, rather than muscular rigidity. * **Delta (δ):** These receptors contribute to supraspinal/spinal analgesia and may modulate emotional states. They do not play a significant role in motor rigidity. * **Sigma (σ):** Formerly classified as an opioid receptor, it is now considered a non-opioid chaperone protein. It is associated with hallucinations and mydriasis (e.g., by drugs like Pentazocine), but not classic opioid rigidity. **3. Clinical Pearls for NEET-PG:** * **Management:** The rigidity can be so severe that it prevents effective bag-mask ventilation. It is treated with **Neuromuscular Blocking Agents (e.g., Succinylcholine)** or the opioid antagonist **Naloxone**. * **High-Yield Fact:** Fentanyl is the most common culprit in clinical practice. * **Key Site:** The **Nucleus Raphe Pontis** is also implicated in the central mediation of this rigidity.

Q: Which of the following is NOT true about ester local anesthetics?

None of the above.. Local anesthetics (LAs) are chemically classified into two groups: **Esters** and **Amides**. This distinction is critical for understanding their metabolism, stability, and allergic potential. ### **Explanation of the Correct Answer** The correct answer is **D (None of the above)** because all the statements (A, B, and C) accurately describe the properties of ester local anesthetics. Since the question asks which statement is **NOT** true, and all are true, "None of the above" is the only logical choice. ### **Analysis of Options** * **Option A (Unstable in solution):** Esters possess a relatively weak chemical bond that is easily broken. They are heat-labile and have a shorter shelf-life compared to the highly stable amide group. * **Option B & C (Hydrolyzed in plasma by cholinesterase):** Unlike amides (which undergo slow hepatic metabolism), esters are rapidly hydrolyzed in the plasma by the enzyme **pseudocholinesterase** (butyrylcholinesterase). This results in a very short plasma half-life. ### **High-Yield Clinical Pearls for NEET-PG** * **Metabolite & Allergy:** Ester LAs are metabolized into **Para-aminobenzoic acid (PABA)**. PABA is highly immunogenic and is responsible for the allergic reactions associated with esters. Amides rarely cause true allergies. * **Pseudocholinesterase Deficiency:** Patients with atypical or deficient pseudocholinesterase are at risk of systemic toxicity due to the prolonged half-life of ester LAs. * **The "i" Rule:** To distinguish them easily—Amides have two "i"s in their name (L**i**doca**i**ne, Pr**i**loca**i**ne, Bup**i**vaca**i**ne), while Esters have only one "i" (Procaine, Chloroprocaine, Tetracaine, Benzocaine). * **Cocaine Exception:** Cocaine is the only ester LA that is primarily metabolized in the liver and also undergoes significant renal excretion.

Q: What is the mechanism of action of Levetiracetam?

Blocking SV2A protein. **Explanation:** **Mechanism of Action (Correct Answer: A)** Levetiracetam is a unique antiepileptic drug (AED) that does not act through traditional ion channel or GABAergic pathways. Its primary mechanism involves binding to the **Synaptic Vesicle Protein 2A (SV2A)**. This protein is located on the membranes of presynaptic vesicles and is involved in vesicle docking and fusion. By binding to SV2A, Levetiracetam modulates the release of neurotransmitters (specifically reducing the release of excitatory glutamate), thereby stabilizing neuronal excitability. **Analysis of Incorrect Options:** * **Option B (Inhibiting reuptake of GABA):** This is the mechanism of **Tiagabine**, which inhibits the GAT-1 transporter, increasing GABA concentration in the synaptic cleft. * **Option C (Inhibiting GABA transaminase):** This is the mechanism of **Vigabatrin**, which prevents the breakdown of GABA, leading to increased inhibitory levels. * **Option D (Calcium channel blocker):** This describes drugs like **Ethosuximide** (T-type Ca²⁺ channels) or **Gabapentin/Pregabalin** (α2δ subunit of N-type Ca²⁺ channels). **High-Yield Clinical Pearls for NEET-PG:** * **Pharmacokinetics:** It has near 100% bioavailability, minimal protein binding, and is excreted unchanged in urine (no CYP450 involvement), making it ideal for patients on multiple medications. * **Side Effects:** The most characteristic side effect is **behavioral changes** (irritability, aggression, or "Levy-rage"). * **Clinical Use:** It is a broad-spectrum AED used for focal-onset seizures, myoclonic seizures (JME), and generalized tonic-clonic seizures. * **Brivaracetam:** A newer analog with a higher affinity for SV2A than Levetiracetam.

Q: Allergic reactions with amino ester local anesthetics are primarily due to which metabolite?

Para-aminobenzoic acid. **Explanation:** **1. Why Option A is Correct:** Amino ester local anesthetics (e.g., Procaine, Benzocaine, Tetracaine) are metabolized by **plasma pseudocholinesterase** through hydrolysis. This metabolic pathway produces **Para-aminobenzoic acid (PABA)** as a primary byproduct. PABA is a known potent allergen that can trigger Type I (anaphylactic) or Type IV (delayed) hypersensitivity reactions in susceptible individuals. **2. Why Other Options are Incorrect:** * **Option B (Nitrosoamine):** Nitrosoamines are not metabolites of local anesthetics. They are generally associated with dietary sources or tobacco and are known carcinogens, but they play no role in local anesthetic allergy. * **Option C & D:** Since PABA is the specific culprit, these options are incorrect. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Esters vs. Amides:** True allergic reactions are much more common with **Esters** due to PABA. Allergic reactions to **Amides** (Lidocaine, Bupivacaine) are extremely rare. * **Cross-Reactivity:** There is significant cross-reactivity among different ester anesthetics because they all produce PABA. However, there is **no cross-reactivity** between the ester and amide groups. If a patient is allergic to an ester, an amide can usually be safely used. * **Preservatives:** Often, "allergic reactions" attributed to amide anesthetics are actually reactions to the preservative **Methylparaben**, which is chemically similar to PABA. * **Mnemonic:** To distinguish the two classes: Amides have **two "i"s** in their name (L**i**doca**i**ne, Pr**i**loca**i**ne, Bup**i**vaca**i**ne), while Esters have only **one "i"** (Proca**i**ne, Chloroproca**i**ne).

Q: What is the most effective non-habit forming sedative?

Zolpidem. **Explanation:** **Zolpidem** is the correct answer because it belongs to the "Z-drugs" (Non-benzodiazepine hypnotics), which are currently the first-line treatment for short-term insomnia. **Why Zolpidem is correct:** Unlike traditional Benzodiazepines (BZDs), Zolpidem is a selective agonist at the **α1 subunit** of the GABA-A receptor (BZ1 site). This selectivity provides potent sedative and hypnotic effects while lacking significant anticonvulsant, muscle relaxant, or anxiolytic properties. Crucially, Zolpidem has a **lower potential for tolerance, dependence, and "hangover" effects** compared to BZDs, making it the preferred "non-habit forming" option in clinical practice. **Why other options are incorrect:** * **Lorazepam (A) & Flurazepam (C):** These are classic Benzodiazepines. They bind non-selectively to various GABA-A subunits (α1, α2, α3, α5). This lack of selectivity leads to a higher risk of physical dependence, cognitive impairment, and significant withdrawal symptoms upon discontinuation. * **Trazodone (D):** While often used off-label for insomnia due to its sedative side effects (H1 and α1 blockade), it is primarily an antidepressant (SARI). It is not as effective as Zolpidem for sleep induction and is associated with side effects like priapism and orthostatic hypotension. **High-Yield Clinical Pearls for NEET-PG:** * **Antidote:** Flumazenil reverses the effects of both BZDs and Z-drugs (Zolpidem, Zaleplon, Eszopiclone). * **Zaleplon:** Has the shortest half-life among Z-drugs; ideal for sleep-onset insomnia. * **Eszopiclone:** The only Z-drug approved for long-term use (up to 6 months). * **Melatonin Agonist:** Ramelteon is another non-habit forming option, specifically acting on MT1 and MT2 receptors in the suprachiasmatic nucleus.

Q: What is the first-line treatment for trigeminal neuralgia?

Carbamazepine. **Explanation:** **Trigeminal Neuralgia (Tic Douloureux)** is characterized by sudden, severe, brief, stabbing, or shock-like recurrent pain in the distribution of one or more branches of the fifth cranial nerve. **Why Carbamazepine is the Correct Answer:** **Carbamazepine** is the **drug of choice (DOC)** and the first-line treatment for trigeminal neuralgia. It acts by blocking **use-dependent voltage-gated sodium channels**, which stabilizes neuronal membranes and inhibits the repetitive firing of the trigeminal nerve. It provides significant pain relief in approximately 70-80% of patients. **Why Other Options are Incorrect:** * **A. Neurectomy:** This is a destructive surgical procedure involving the cutting of the nerve. It is considered only when medical management fails and less invasive surgical options are exhausted. * **C. Regional nerve block:** While it can provide temporary relief, it is not a first-line or long-term management strategy. * **D. Radiofrequency (Rhizotomy):** This is a minimally invasive surgical option (thermal ablation of the nerve root). It is indicated only for patients who are refractory to medical therapy or cannot tolerate the side effects of drugs. **High-Yield Clinical Pearls for NEET-PG:** * **Second-line drugs:** Oxcarbazepine (often preferred due to fewer side effects), Baclofen, or Lamotrigine. * **Surgical DOC:** **Microvascular Decompression (MVD)**, also known as the Jannetta procedure, is the most effective surgical treatment for cases caused by vascular compression. * **Carbamazepine Side Effects:** Diplopia, ataxia, and most importantly, **Stevens-Johnson Syndrome (SJS)**, especially in patients with the **HLA-B*1502** allele. It is also a potent hepatic enzyme inducer. * **Monitoring:** Periodic CBC is required due to the risk of **agranulocytosis** and aplastic anemia.

Question 1

What are the CNS affections of a local anesthetic agent?

Accepted Answer

All of the above

Answer

Convulsion

Answer

Perioral numbness

Answer

Depression

Question 2

Which of the following is true about benzodiazepines?

Accepted Answer

GABA facilitator

Answer

GABA mimetic

Answer

Not a safe drug

Answer

High abuse potential

Question 3

Muscular rigidity caused by opioids is due to agonistic effect on which receptor?

Accepted Answer

Mu

Answer

Kappa

Answer

Delta

Answer

Sigma

Question 4

Morphine can be administered by all of the following routes except:

Accepted Answer

Subarachnoid

Answer

Intramuscular

Answer

Transdermal

Answer

Epidural

Question 5

Which of the following is NOT true about ester local anesthetics?

Accepted Answer

None of the above.

Answer

They are unstable in solution.

Answer

They are hydrolyzed in plasma.

Answer

They are hydrolyzed by cholinesterase enzymes.

Question 6

True about anticonvulsants in pregnancy?

Accepted Answer

Monotherapy is generally recommended.

Answer

Carbamazepine is safe in pregnancy.

Answer

Lamotrigine is safe in pregnancy.

Answer

Newer anticonvulsant drugs are always safe in pregnancy.

Question 7

What is the mechanism of action of Levetiracetam?

Accepted Answer

Blocking SV2A protein

Answer

Inhibiting reuptake of GABA

Answer

Inhibiting GABA transaminase enzyme

Answer

Calcium channel blocker

Question 8

Allergic reactions with amino ester local anesthetics are primarily due to which metabolite?

Accepted Answer

Para-aminobenzoic acid

Answer

Nitrosoamine

Answer

Both Para-aminobenzoic acid and Nitrosoamine

Answer

Neither Para-aminobenzoic acid nor Nitrosoamine

Question 9

What is the most effective non-habit forming sedative?

Accepted Answer

Zolpidem

Answer

Lorazepam

Answer

Flurazepam

Answer

Trazodone

Question 10

What is the first-line treatment for trigeminal neuralgia?

Accepted Answer

Carbamazepine

Answer

Neurectomy

Answer

Regional nerve block

Answer

Radiofrequency

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?